The global plastic pollution crisis and the fallout from the COVID-19 pandemic – where billions of single-use diagnostic tests were discarded – is prompting businesses and researchers to develop new and more sustainable rapid diagnostic tests.
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules | Psychedelic Invest
PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and